(Q38876705)
Statements
1 reference
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial (English)
1 reference
Laurent Misery
1 reference
Pascal Joly
1 reference
Maud Maho-Vaillant
1 reference
Catherine Prost-Squarcioni
1 reference
Vivien Hebert
1 reference
Estelle Houivet
1 reference
Sébastien Calbo
1 reference
Frédérique Caillot
1 reference
Marie Laure Golinski
1 reference
Bruno Labeille
1 reference
Catherine Picard-Dahan
1 reference
Marie-Aleth Richard
1 reference
Jean David Bouaziz
1 reference
Sophie Duvert-Lehembre
1 reference
Philippe Bernard
1 reference
Frederic Caux
1 reference
Marina Alexandre
1 reference
Saskia Ingen-Housz-Oro
1 reference
Emmanuel Delaporte
1 reference
Gaelle Quereux
1 reference
Alain Dupuy
1 reference
Sebastien Debarbieux
1 reference
Martine Avenel-Audran
1 reference
Michel D'Incan
1 reference
Christophe Bedane
1 reference
Nathalie Bénéton
1 reference
Denis Jullien
1 reference
Laurent Machet
1 reference
Olivier Dereure
1 reference
Bruno Sassolas
1 reference
Thomas Vermeulin
1 reference
Jacques Benichou
1 reference
Philippe Musette
1 reference
French study group on autoimmune bullous skin diseases
1 reference
22 March 2017
1 reference
1 reference
389
1 reference
10083
1 reference
2031-2040
1 reference
Identifiers
1 reference
1 reference